comparemela.com
  1. Home
  2. Live Updates
  3. European Hematology Association Congress - Breaking News

Latest Breaking News On - European hematology association congress - Page 1 : comparemela.com

SL-172154 Receives FDA Orphan Drug Designation in AML

SL-172154 has been granted orphan drug designation from the FDA in acute myeloid leukemia.

Taylor schreiberInternational prognostic scoring systemShattuck labs incDrug administrationEuropean hematology association congressShattuck labsHematology association congress

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJorge cortesDoug morrisPeter nielsenEuropean hematology associationPath holdings to present dataGeorgia cancer centerPath holdingsPath holdings incEuropean hematology association congressExchange commissionCompany phaseStern investor relations incPresent dataHematology associationChief executive officer

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myel

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myel
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Hong kongXiaojun huangUniversity people hospitalNational cancer instituteEuropean hematology association congressDrug administrationChina limitedFlorham parkProf xiaojun huangPeking university peopleHematological malignancies

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Hong kongBen atwell alex shawAnn hematolXiaojun huangZhou yiAtholl tweedieChina limitedUniversity people hospitalDrug administrationExchange commissionEuropean hematology association congressStock exchange of hong kongNational cancer instituteProf xiaojun huangPeking university peopleSecurities litigation reform act

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China

HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Hong kongAnn hematolBen atwell alex shawXiaojun huangZhou yiAtholl tweedieNational cancer instituteDrug administrationExchange commissionStock exchange of hong kongEuropean hematology association congressUniversity people hospitalChina limitedRefractory acute myeloid leukemiaProf xiaojun huangPeking university people
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.